Table 2.
Univariate analysis of the main laboratory findings for AOSD patients and controls.
| Variables | AOSD patients, n = 80 % | Controls, n = 60 % | P | Odds ratio [CI 95%] |
|---|---|---|---|---|
| Leukocytosis | 67/80 (83.7) | 20/60 (33.3) | <10−6 | 10.3 [4.3–25] |
| Neutrophils ≥ 75% | 68/80 (85) | 16/60 (26.6) | <10−6 | 15.6 [6.3–39.8] |
| Neutrophils ≥ 80% | 51/80 (63.7) | 10/60 (16.6) | <10−6 | 8.8 [3.6–21.8] |
| Mean neutrophils % | 80 ± 7.6 | 67.56 ± 11.61 | <10−6 | – |
| Lymphopenia % | 15 (18.7) | 16 (26.7) | .3 | |
| Mean NLR | 10 ± 10.24 | 4.48 ± 4.55 | 10−4 | – |
| DNI > 2% | 3/80 (3.75) | 1/60 (1.7) | .8 | – |
| Mean hemoglobin, g/dL | 9.6 ± 1.7 | 10.96 ± 2 | 4 × 10−4 | – |
| Mean ESR rate, mm | 106 ± 22 | 74.1 ± 42.9 | <10−6 | – |
| Mean CRP, mg/L | 136.8 ± 87.57 | 86.68 ± 87.47 | .001 | – |
| Beta-2 microglobulin (> N) | 6/22 (27.2) | 2/16 (12.5) | .4 | 2.6 [0.4–22.6] |
| Mean beta-2 microglobulin | 2.04 ± 0.99 | 1.56 ± 0.72 | .1 | – |
| Serum ferritin > N | 70/80 (87.5) | 19/60 (31.7) | <10−6 | 15.11 [5.9–39.4] |
| Serum ferritin ≥ 5 N | 59/80 (73.7) | 4/60 (7.8) | <10−6 | 39.3 [11.7–146] |
| 25.9 [2.6–630.9] | ||||
| Glycosylated ferritin ≤ 25% | 42/47 (89.2) | 1/08 (12.5) | <10−6 | 58.8 [5.1–1585] |
| Negative ANA | 72/80 (90) | 46/60 (76.7) | .03 | 2.7 [0.97–8.1] |
| Negative anti-CCP | 80/80 (100) | 54/60 (90) | .01 | – |
| Negative FR | 80/80 (100) | 54/60 (90) | .01 | – |